milrinone and flosequinan

milrinone has been researched along with flosequinan in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hague, NL; Hunneyball, IM; Loh, E; Morgan, JP; Perreault, CL; Sim, MF1
Maitland, LA; Morgan, KG; Resnick, MS1
Falotico, R; Haertlein, BJ; Lakas-Weiss, CS; Salata, JJ; Tobia, AJ1
Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE1
Dickinson, K; Foster, GA; Frodsham, G; Jones, RB1
Britton, LW; Ferraris, VA; Kirker, ML; Sim, MF; Wallace, AM; Weishaar, RE1
Miao, L; Morgan, JP; Perreault, CL; Travers, KE1

Other Studies

7 other study(ies) available for milrinone and flosequinan

ArticleYear
Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.
    British journal of pharmacology, 1992, Volume: 106, Issue:3

    Topics: Animals; Calcium; Colforsin; Dose-Response Relationship, Drug; Ferrets; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyridones; Quinolines; Quinolones; Stimulation, Chemical; Vasodilator Agents

1992
Flosequinan, a vasodilator with a novel mechanism of action.
    British journal of pharmacology, 1991, Volume: 102, Issue:4

    Topics: Aequorin; Animals; Aorta, Thoracic; Calcium; Ferrets; In Vitro Techniques; Male; Milrinone; Muscle Contraction; Nitroprusside; Phenylephrine; Potassium; Pyridones; Quinolines; Vasodilator Agents

1991
Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:3

    Topics: Amrinone; Anesthesia; Animals; Ferrets; Heart Failure; Heart Rate; Hemodynamics; In Vitro Techniques; Infusions, Intravenous; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Pentobarbital; Pyridones; Quinolines; Vasodilator Agents

1989
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:5

    Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents

1994
Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
    British journal of pharmacology, 1993, Volume: 108, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Anesthesia; Animals; Arrhythmias, Cardiac; Blood Pressure; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Enzyme Activation; Isoproterenol; Male; Milrinone; Myocardial Ischemia; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Quinolines; Rats; Rats, Wistar; Vasodilator Agents

1993
Relationship between inotropic activity and phosphodiesterase inhibition for flosequinan and milrinone.
    European journal of pharmacology, 1993, Jun-04, Volume: 236, Issue:3

    Topics: Humans; In Vitro Techniques; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Quinolines; Quinolones; Vasodilation

1993
Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium.
    European journal of pharmacology, 1997, Feb-26, Volume: 321, Issue:2

    Topics: Aequorin; Animals; Calcium Channel Blockers; Cardiotonic Agents; Carrier Proteins; Enzyme Inhibitors; Ferrets; Heart; Hydralazine; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Procaine; Pyridones; Quinolines; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Tetrodotoxin; Vasodilator Agents; Verapamil

1997